Dominant β-thalassemia - A rare entity.

Khera, Rachna; Singh, Tejinder.
Indian J Pathol Microbiol ; 2012 Jul-Sept 55(3): 422-423
Artículo en Inglés | IMSEAR | ID: sea-142291

Documentos relacionados

  1. Foetal haemoglobin inducers for reducing blood transfusion in non-transfusion-dependent beta-thalassaemias.
  2. Efficacy and Safety of Gene Therapy for ß-Thalassemia.
  3. Adenine base editor-mediated correction of the common and severe IVS1-110 (G>A) ß-thalassemia mutation.
  4. CRISPR/Cas9, a promising approach for the treatment of ß-thalassemia: a systematic review.
  5. The continuing global challenges of treating patients with beta-thalassemia.
  6. ß-Thalassemia Trait Caused by <i>SUPT5H</i> Defects: Another Case Report.
  7. Defining curative endpoints for transfusion-dependent ß-thalassemia in the era of gene therapy and gene editing.
  8. Safety and efficacy of peripheral blood stem cells collection in healthy children and pediatric patients with thalassemia major weighing 20 kg or less.
  9. Therapeutic Effects of Hematopoietic Stem Cell Derived From Gene-Edited Mice on ß654-Thalassemia.
  10. De novo mutation rates at the single-mutation resolution in a human <i>HBB</i> gene region associated with adaptation and genetic disease.